Publication
Health Canada’s proposal to streamline approvals may accelerate biosimilar patent litigation
Health Canada has proposed a major change to the regulation of biosimilar drugs that may accelerate biologic patent liti...
Publication
Health Canada has proposed a major change to the regulation of biosimilar drugs that may accelerate biologic patent liti...
Publication
The Commissioner of Patents has once again determined that two patent applications for computer-implemented inventions f...
Publication
It is risky to let a registered trademark go unused in Canada. If not used for three years, a trademark registration is ...
Publication
Health Canada has proposed a major change to the regulation of biosimilar drugs that may accelerate biologic patent liti...
Publication
The Commissioner of Patents has once again determined that two patent applications for computer-implemented inventions f...
© Norton Rose Fulbright LLP 2025